Stratagene (NASDAQ:STGN)
Historical Stock Chart
From Jun 2019 to Jun 2024
![Click Here for more Stratagene Charts. Click Here for more Stratagene Charts.](/p.php?pid=staticchart&s=N%5ESTGN&p=8&t=15)
--Stratagene Corporation (Nasdaq:STGN), today announced that it will
release fourth quarter financial results on March 6, 2007
after the market close. The Company will also host a conference call and
webcast on March 6, 2007 at 1:30 p.m. Pacific Time to
discuss the Company’s fourth quarter and full
year results, and current corporate developments. The dial-in number for
the conference call is 800-257-2182 for domestic participants and
303-262-2138 for international participants.
A taped replay of the conference call will also be available beginning
approximately one hour after the call’s
conclusion and will remain available for 7 days. It can be accessed by
dialing 800-405-2236 for domestic callers and 303-590-3000 for
international callers, using the passcode 11085628#. To access the live
webcast of the call, go to Stratagene’s
website at www.stratagene.com
and click on the Investors icon. An archived webcast will also be
available at www.stratagene.com.
About Stratagene Corporation
Stratagene is a developer, manufacturer and marketer of specialized life
science research and diagnostic products. The Company's life science
research unit supports advances in science by inventing, manufacturing
and distributing products that simplify, accelerate and improve
research. These products are used throughout the academic, industrial
and government research sectors in fields spanning molecular biology,
genomics, proteomics, drug discovery and toxicology. The Company's
diagnostic unit develops and manufactures products for urinalysis as
well as high quality automated instrument and reagent systems that use
blood samples to test for more than 1,000 different allergies and
autoimmune disorders. In addition, by combining its expertise in
diagnostics and molecular biology, as well as its experience with FDA
regulatory procedures, the Company is pursuing opportunities to expand
its product portfolio to include molecular diagnostic kits and
instrumentation. More information is available at www.stratagene.com.